Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 35(9): 1193-7, 2016 Mar 03.
Article in English | MEDLINE | ID: mdl-25982280

ABSTRACT

Scribble complex proteins maintain apicobasal polarity, regulate cell fate determination and function as tumour suppressors in epithelial tissue. Despite evidence that the function of Scribble is maintained in the lymphocyte lineage, we still understand little about its role as a tumour suppressor in haematological malignancies. Using the Eµ-myc model of Burkitt's lymphoma we investigated the role of Scribble in lymphomagenesis. We found that contrary to its well-documented tumour suppressor role in epithelial tissue, loss of Scribble expression delayed the expansion of peripheral B cells and delayed the onset of Eµ-myc-driven lymphoma. This was despite upregulated ERK phosphorylation levels in Scribble-deficient tumours, which are associated with loss of Scribble expression and the development of more aggressive Burkitt's lymphoma. Interestingly, the developmental stage of lymphoma was unaffected by Scribble expression challenging any role for Scribble in fate determination in the haematopoetic lineage. These data provide evidence for oncogenic properties of Scribble in Myc-driven B-cell lymphomagenesis, reinforcing recent findings that overexpression of a mutant form of Scribble can act as an oncogene in epithelial cells. Our results support the growing appreciation that the tumour regulatory functions of Scribble, and other polarity protein family members, are context dependent.


Subject(s)
Burkitt Lymphoma/genetics , Lymphoma, B-Cell/genetics , Membrane Proteins/biosynthesis , Oncogenes , Tumor Suppressor Proteins/biosynthesis , Animals , Apoptosis/genetics , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , Burkitt Lymphoma/pathology , Cell Line, Tumor , Humans , Lymphoma, B-Cell/pathology , Membrane Proteins/genetics , Transcriptional Activation/genetics , Tumor Suppressor Proteins/genetics
2.
Cell Death Differ ; 15(4): 708-17, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18202705

ABSTRACT

Human GraB (hGraB) preferentially induces apoptosis via Bcl-2-regulated mitochondrial damage but can also directly cleave caspases and caspase substrates in cell-free systems. How hGraB kills cells when it is delivered by cytotoxic lymphocytes (CL) and the contribution of hGraB to CL-induced death is still not clear. We show that primary human natural killer (hNK) cells, which specifically used hGraB to induce target cell death, were able to induce apoptosis of cells whose mitochondria were protected by Bcl-2. Purified hGraB also induced apoptosis of Bcl-2-overexpressing targets but only when delivered at 5- to 10-fold the concentration required to kill cells expressing endogenous Bcl-2. Caspases were critical in this process as inhibition of caspase activity permitted clonogenic survival of Bcl-2-overexpressing cells treated with hGraB or hNK cells but did not protect cells that only expressed endogenous Bcl-2. Our data therefore show that hGraB triggers caspase activation via mitochondria-dependent and mitochondria-independent mechanisms that are activated in a hierarchical manner, and that the combined effects of Bcl-2 and direct caspase inhibition can block cell death induced by hGraB and primary hNK cells.


Subject(s)
Apoptosis , Caspases/metabolism , Granzymes/metabolism , Killer Cells, Natural/enzymology , Mitochondria/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Secretory Vesicles/enzymology , Amino Acid Chloromethyl Ketones/pharmacology , Apoptosis/drug effects , Caspase Inhibitors , Cell Culture Techniques , Cells, Cultured , Cysteine Proteinase Inhibitors/pharmacology , Dipeptides/pharmacology , Enzyme Activation , Granzymes/antagonists & inhibitors , Granzymes/genetics , HeLa Cells , Humans , Killer Cells, Natural/drug effects , Mitochondria/enzymology , Mitochondrial Membranes/metabolism , Permeability , Protease Inhibitors/pharmacology , Proto-Oncogene Proteins c-bcl-2/genetics , Secretory Vesicles/drug effects , Time Factors , Transfection , X-Linked Inhibitor of Apoptosis Protein/metabolism
4.
Infect Immun ; 68(6): 3337-43, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10816482

ABSTRACT

Experiments were performed using the standardized murine model of Helicobacter pylori infection to determine the immunogenicity of H. pylori outer membrane vesicles in immune protection. These vesicles, which are naturally shed from the surface of the bacterium, induce a protective response when administered intragastrically to mice in the presence of cholera holotoxin, despite the absence of the urease enzyme and associated Hsp54 chaperonin. Immunoblotting identified a specific serum immunoglobulin G (IgG) response to an 18-kDa outer membrane protein in a significant number of immunized animals. This commonly expressed, immunodominant protein was subsequently identified as lipoprotein 20 (Lpp20). Hybridoma backpacks secreting an IgG1 subclass monoclonal antibody to Lpp20 were generated in H. pylori-infected mice and were found to significantly reduce bacterial numbers, providing evidence that this surface-exposed antigen is a true vaccine candidate and not merely an antigenic marker for successful, protective immunization.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/immunology , Bacterial Vaccines/immunology , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Lipoproteins/immunology , Animals , Antibodies, Bacterial/therapeutic use , Antibodies, Monoclonal/therapeutic use , Bacterial Vaccines/therapeutic use , Female , Helicobacter Infections/prevention & control , Immunization, Passive , Immunodominant Epitopes , Mice , Mice, Inbred BALB C , Vaccination
5.
Microbios ; 83(337): 217-28, 1995.
Article in English | MEDLINE | ID: mdl-8577260

ABSTRACT

An association between Mycobacterium paratuberculosis and Crohn's disease is suspected but the evidence remains controversial. Using a one-step DNA extraction procedure with the thermophilic protease PRETAQ and amplification by the polymerase chain reaction, M. paratuberculosis DNA was detected in 22% of patients with Crohn's disease, and in 13% of patients with ulcerative colitis. M. paratuberculosis DNA was not found in any biopsy tissue from control non-inflammatory bowel disease patients. The biopsy tissues in which M. paratuberculosis was detected all came from regions which were inflamed when viewed microscopically. Overall, 7.7% of biopsies from such inflamed areas were positive. This low frequency of detection could be explained on the basis of extremely low abundance of the organism in relation to the area of mucosa sampled, or be consistent with a non-aetiological role for M. paratuberculosis in inflammatory bowel disease.


Subject(s)
Inflammatory Bowel Diseases/microbiology , Mycobacterium Infections/complications , Mycobacterium avium subsp. paratuberculosis/physiology , Animals , Base Sequence , Biopsy , Colitis, Ulcerative/microbiology , Colitis, Ulcerative/pathology , Colonoscopy , Crohn Disease/microbiology , Crohn Disease/pathology , DNA, Bacterial/analysis , Female , Humans , Inflammatory Bowel Diseases/pathology , Molecular Sequence Data , Mycobacterium avium subsp. paratuberculosis/genetics , Mycobacterium avium subsp. paratuberculosis/isolation & purification , Polymerase Chain Reaction , Sensitivity and Specificity
6.
Respir Care ; 22(9): 912, 1977 Sep.
Article in English | MEDLINE | ID: mdl-10314882
SELECTION OF CITATIONS
SEARCH DETAIL
...